99
Fatores de risco modificáveis: tabagismo, sedentarismo, obesidade, síndrome metabólica,
dislipidémia, hipertensão arterial, diabetes e fatores psicossociais
Bibliografia
1. Perk J, De Backer G, Cohlke H, et al. European guidelines on cardiovascular disease preven-
tion in clinical practice (version 2012). Eur Heart J. 2012; 33: 1635-1701.
2. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated
with myocardial infarction in 52 countries (the INTERHEART Study): case-control study.
Lancet. 2004; 364: 937-952.
3. Tu JV. Reducing the global burden of stroke: INTERSTROKE. Lancet 2010; 376: 74-75.
4. Prevenção e controlo do tabagismo em números – 2014. Portugal. Programa nacional para a
prevenção e controlo do tabagismo. Direção Geral de Saúde, 2014.
5. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the Global
Registry of Acute Coronary Events. Arch Intern Med. 2003; 163: 2345-2353.
6. Ferreira Santos J, Aguiar C, Gavina C, et al. Registo Nacional de Síndromes Coronárias
Agudas: sete anos de actividade em Portugal. Rev Port Cardiol. 2009; 28: 1465-1500.
7. Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: A European Society of cardiology
survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24
European countries. Eur J Prev Cardiol. 2015. PMID: 25687109.
8. João Cardoso. Tabagismo. Manual de Reabilitação Cardíaca. Lisboa, Sociedade Portuguesa
Cardiologia 2013; P137 – 140.
9. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guidelines for the manage-
ment of patients with non-ST-elevation acute coronary syndromes. Circulation. 2014; 130:
e344-e426.
10. Smith SC, Benjamin EJ, Boow RO, et al. AHA/ACCF Secondary prevention and risk reduction
therapy for patients with coronary and other atherosclerotic vascular diseases: 2011 update.
Circulation. 2011; 124: 2458-2473
11. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guidelines for the manage-
ment of ST-elevation myocardial infarction. Circulation. 2013; 127: e362-e425.
12. Hamm CW, Bassand JP Agewall S, et al. ESC Guidelines for the management of acute coro-
nary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart
J. 2011; 32: 2999-3054.
13. Steg G, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial
infarction in patients presenting with ST segment elevation. Eur Heart J. 2012; 33: 2569-2619.
14. Windecker S, Kohl P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascula-
rization. Eur Heart J. 2014; 35:254-619
15. Cameron AJ, Shaw JE, Zimmet PZ. The Metabolic Syndrome: Prevalence in worldwide popu-
lations. Endocrin Met Clinics North Am. Metabolic Syndrome: Part 1. 2004; 33: 351-76.
16. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk. A
systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56:1113-1132.
17. Lavie CJ, McAuley PA, Church TS, et al. Obesity and cardiovascular diseases: implications
regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014; 63:
1345-1354.
